Needham Keeps Price Targets Unchanged for Endava, Snowflake and Harmony
Needham maintained its price targets for Endava, Snowflake and Harmony Biosciences at $5, $450 and $50 per share, respectively.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Dow Jones Newswires, citing ratings information from Benzinga, reported that Needham maintained its $5.00-per-share price target for Endava, whose ticker is DAVA.
Needham also kept Snowflake’s target unchanged at $450.00 per share; the company trades under SNOW. The firm maintained its target for Harmony Biosciences at $50.00 per share, with HRMY as its ticker.
All three actions were published on October 12, 2026.
why it matters
Analyst price-target changes can affect investor attention around individual stocks. In these cases, Needham left its existing targets unchanged for all three companies.
instruments
sources
- Endava Price Target Maintained With a $5.00/Share by Needham — Dow Jones Newswires, 12 October 2026 at 09:48 UTC
- Snowflake Price Target Maintained With a $450.00/Share by Needham — Dow Jones Newswires, 12 October 2026 at 10:25 UTC
- Harmony Biosciences Price Target Maintained With a $50.00/Share by Needham — Dow Jones Newswires, 12 October 2026 at 13:37 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗